131 related articles for article (PubMed ID: 18566481)
21. Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells.
Hao H; Tyshenko MG; Walker VK
Gene Expr; 1996; 6(4):231-9. PubMed ID: 9196078
[TBL] [Abstract][Full Text] [Related]
22. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR
Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268
[TBL] [Abstract][Full Text] [Related]
23. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
24. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
Ercikan-Abali EA; Waltham MC; Dicker AP; Schweitzer BI; Gritsman H; Banerjee D; Bertino JR
Mol Pharmacol; 1996 Mar; 49(3):430-7. PubMed ID: 8643082
[TBL] [Abstract][Full Text] [Related]
25. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
Domin BA; Grill SP; Bastow KF; Cheng YC
Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
Bürkle A; Heilbronn R; zur Hausen H
Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
[TBL] [Abstract][Full Text] [Related]
27. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
Domin BA; Grill SP; Cheng Y
Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
[TBL] [Abstract][Full Text] [Related]
28. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.
Urlaub G; Landzberg M; Chasin LA
Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140
[TBL] [Abstract][Full Text] [Related]
29. Cancer research: from folate antagonism to molecular targets.
Bertino JR
Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and preliminary in vitro screening of lipophilic alpha, gamma-bis(amides) as potential prodrugs of methotrexate.
Pignatello R; Sorrenti V; Spampinato G; Pecora T; Panico A; Di Giacomo C; Fresta M; Vanella A; Puglisi G
Anticancer Drug Des; 1996 Apr; 11(3):253-64. PubMed ID: 8663912
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
Evenson DA; Adams J; McIvor RS; Wagner CR
J Med Chem; 1996 Apr; 39(9):1763-6. PubMed ID: 8627598
[TBL] [Abstract][Full Text] [Related]
33. Genetic changes in methotrexate-resistant mosquito cells.
Shotkoski FA; Fallon AM
Arch Insect Biochem Physiol; 1990; 15(2):79-92. PubMed ID: 1724612
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.
Cody V; Galitsky N; Luft JR; Pangborn W; Blakley RL; Gangjee A
Anticancer Drug Des; 1998 Jun; 13(4):307-15. PubMed ID: 9627670
[TBL] [Abstract][Full Text] [Related]
35. [Methotrexate and its drug resistance].
Nagura E
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237
[TBL] [Abstract][Full Text] [Related]
36. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
37. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
Volpato JP; Pelletier JN
Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
[TBL] [Abstract][Full Text] [Related]
38. Light activates reduction of methotrexate by NADPH in the ternary complex with Escherichia coli dihydrofolate reductase.
Chen YQ; Gulotta M; Cheung HT; Callender R
Photochem Photobiol; 1999 Jan; 69(1):77-85. PubMed ID: 10063803
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the coexisting multiple mechanisms of methotrexate resistance in mouse 3T6 R50 fibroblasts.
Assaraf YG; Feder JN; Sharma RC; Wright JE; Rosowsky A; Shane B; Schimke RT
J Biol Chem; 1992 Mar; 267(9):5776-84. PubMed ID: 1372892
[TBL] [Abstract][Full Text] [Related]
40. Kinetic investigation of methotrexate resistant human dihydrofolate reductase (hDHFR) mutants at Phe31.
Chunduru SK; Appleman JR; Blakley RL
Adv Exp Med Biol; 1993; 338():507-10. PubMed ID: 8304168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
